Chaplan, Sandra R.
WAVE Team,
United States
2025 Rank: 101748
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 339 out of 112089 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 101748 | 115753 |
| Total Cites | 10939 | 11417 |
| H-index | 32 | 32 |
| Hm-index | 10 | 10 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 25 | 25 |
| Number of Single+First Authored Papers | 10 | 10 |
| Total Cites to Single+First Authored Papers | 7342 | 7530 |
| Number of Single+First+Last Authored Papers | 27 | 27 |
| Total Cites to Single+First+Last Authored Papers | 8288 | 8549 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 9838 | 10112 |
| Ratio of Total Citations to Distinct Citing Papers | 1.11 | 1.13 |
| Self-Citation Percentage |
4.19%
|
|
Chaplan, Sandra R.
Janssen Research & Development,
United States
2024 Rank: 100523
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 331 out of 105998 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 100523 | 112186 |
| Total Cites | 10391 | 10860 |
| H-index | 30 | 31 |
| Hm-index | 9 | 10 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 25 | 25 |
| Number of Single+First Authored Papers | 10 | 10 |
| Total Cites to Single+First Authored Papers | 6905 | 7086 |
| Number of Single+First+Last Authored Papers | 27 | 27 |
| Total Cites to Single+First+Last Authored Papers | 7825 | 8078 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 9307 | 9576 |
| Ratio of Total Citations to Distinct Citing Papers | 1.12 | 1.13 |
| Self-Citation Percentage |
4.32%
|
|
Chaplan, Sandra R.
Janssen Research & Development,
United States
2023 Rank: 98890
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Neurology & Neurosurgery
Rank in SubField 1: 319 out of 99369 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 98890 | 110487 |
| Total Cites | 9794 | 10259 |
| H-index | 29 | 30 |
| Hm-index | 9 | 10 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 23 | 23 |
| Number of Single+First Authored Papers | 10 | 10 |
| Total Cites to Single+First Authored Papers | 6439 | 6617 |
| Number of Single+First+Last Authored Papers | 25 | 25 |
| Total Cites to Single+First+Last Authored Papers | 7320 | 7570 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 8734 | 8999 |
| Ratio of Total Citations to Distinct Citing Papers | 1.12 | 1.14 |
| Self-Citation Percentage |
4.53%
|
|
Chaplan, Sandra R.
Janssen Research & Development,
United States
2022 Rank: 93798
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Neurology & Neurosurgery
Rank in SubField 1: 295 out of 94672 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 93798 | 106521 |
| Total Cites | 9148 | 9604 |
| H-index | 29 | 30 |
| Hm-index | 9 | 9 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 23 | 23 |
| Number of Single+First Authored Papers | 10 | 10 |
| Total Cites to Single+First Authored Papers | 5964 | 6139 |
| Number of Single+First+Last Authored Papers | 26 | 26 |
| Total Cites to Single+First+Last Authored Papers | 6809 | 7056 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 8115 | 8371 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.15 |
| Self-Citation Percentage |
4.75%
|
|
Chaplan, Sandra R.
Janssen Research & Development,
United States
2021 Rank: 90503
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Neurology & Neurosurgery
Rank in SubField 1: 296 out of 88725 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 90503 | 104154 |
| Total Cites | 8853 | 9295 |
| H-index | 29 | 29 |
| Hm-index | 9 | 9 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 22 | 22 |
| Number of Single+First Authored Papers | 10 | 10 |
| Total Cites to Single+First Authored Papers | 5756 | 5927 |
| Number of Single+First+Last Authored Papers | 24 | 24 |
| Total Cites to Single+First+Last Authored Papers | 6583 | 6826 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7847 | 8096 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.15 |
| Self-Citation Percentage |
4.76%
|
|
Chaplan, Sandra R.
Johnson & Johnson Pharmaceutical Research & Development, Raritan,
United States
2020 Rank: 86139
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Neurology & Neurosurgery
Rank in SubField 1: 360 out of 80622 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 86139 | 98306 |
| Total Cites | 8201 | 8619 |
| H-index | 28 | 28 |
| Hm-index | 9 | 9 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 22 | 22 |
| Number of Single+First Authored Papers | 10 | 10 |
| Total Cites to Single+First Authored Papers | 5237 | 5401 |
| Number of Single+First+Last Authored Papers | 24 | 24 |
| Total Cites to Single+First+Last Authored Papers | 6043 | 6274 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7226 | 7463 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.15 |
| Self-Citation Percentage |
4.85%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.